Cargando…
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
Four large randomised trials of paclitaxel in combination with platinum against a platinum-based control treatment have now been published in full, representing around 88% (3588 out of 4057) of patients randomised into the eight known trials of this question. There is substantial heterogeneity in th...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376171/ https://www.ncbi.nlm.nih.gov/pubmed/12373593 http://dx.doi.org/10.1038/sj.bjc.6600567 |